Results 81 to 90 of about 31,404 (216)

Employing a PLGA-TPGS based nanoparticle to improve the ocular delivery of Acyclovir

open access: yesSaudi Pharmaceutical Journal, 2019
Delivering drugs via the ocular route has always been a challenge for poorly soluble drugs. The various anatomical and physiological barriers in the eye cavity hinder the residence of drugs within the corneal and precorneal regions.
Musaed Alkholief   +6 more
doaj  

Acyclovir transport into human erythrocytes.

open access: hybrid, 1988
William B. Mahony   +3 more
openalex   +1 more source

Empirical treatment with parenteral acyclovir in a child with herpes simplex virus hepatitis and acute lymphoblastic leukemia

open access: yesIDCases, 2018
Introduction: Hepatitis secondary to Herpes Simplex Virus (HSV) infection is a complication that often leads to fatal hepatic failure. Early treatment with the anti-viral drug, acyclovir, is life-saving.
Nesreen A. Faqih   +5 more
doaj  

Molecular Analysis of the Pyrimidine Deoxyribonucleoside Kinase Gene of Wild-type and Acyclovir-resistant Strains of Varicella-Zoster Virus

open access: bronze, 1988
M. H. Sawyer   +5 more
openalex   +1 more source

Acyclovir-resistant herpetic keratitis in a solid-organ transplant recipient on systemic immunosuppression

open access: yesClinical Ophthalmology, 2013
Liam Daniel Turner,1 Peter Beckingsale1,2,31Princess Alexandra Hospital; 2Terrace Eye Centre; 3Laser Sight, Brisbane, Queensland, AustraliaPurpose: To report a case of acyclovir-resistant herpetic keratitis in a solid-organ lung transplant recipient that
Turner LD, Beckingsale P
doaj  

VZV Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation in Children: When to Stop?

open access: yesCancer Reports
Background Acyclovir treatment is an efficient prophylaxis to prevent varicella‐zoster virus (VZV) reactivation after allogeneic hematopoietic stem cell transplantation (HSCT).
Eva deBerranger   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy